Immunogenic properties of reverse transcriptase of HIV type 1 assessed by DNA and protein immunization of rabbits

AIDS Research and Human Retroviruses

Volumn 16, Issue 13, 2000, Pages 1269-1280

  Isaguliants, M G ^a   Gudima, S O ^b   Ivanova, O V ^a   Levi, M ^a   Hinkula, J ^a   Garaev, M M ^a   Kochetkov, S N ^b   Wahren, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CELL PROLIFERATION; ENZYME ACTIVITY; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; PLASMID; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; HIV ANTIBODIES; HIV INFECTIONS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PLASMIDS; RABBITS; RECOMBINANT PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, DNA;

EID: 0034284852     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050117032     Document Type: Article

References (49)

1. DNA vaccination for HW
2. DNA increases the potency of vaccination against infectious disease
3. Heterologous protection against influenza by injection of DNA encoding a viral protein
4. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing the NP gene
5. Genetic immunization: A novel method for vaccine development against HIV
6. Nucleic acid vaccination with HIV-1 regulatory genes
7. Recognition of prominent viral epitopes induced by immunization with HIV-1 regulatory genes
8. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA-vaccination
9. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type I infection: Safety and host response
10. Cellular cytotoxic response induced by DNA vaccination in HIV-1 infected patients
11. Retroviral reverse transcriptase: Synthesis, structure and function
12. The reverse transcriptase of HIV-1: From enzymology to therapeutic intervention
13. Immunological characterization of the human immunodeficiency virus type I reverse transcriptase protein by the use of monoclonal antibodies
14. Monoclonal antibodies define linear and conformational epitopes of HIV-1 pol gene products
15. Structure-function relationships of HIV-1 reverse transcriptase determined using monoclonal antibodies
16. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase
17. Characterization and clinical association of antibody inhibitory to HIV-1 reverse transcriptase activity
18. Dose response resistance to HIV-1 MuLV pseudotype virus ex vivo in a hair pin ribozyme mouse model
19. Eukaryotic expression of enzymatically active HIV-1 reverse transcriptase
20. Study on the resistance of HIV-1 to azidothymidine. I. Kinetic study of the interaction of reverse transcriptase and its mutants with substrates and azidothymidine-5'-triphosphate
21. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids
22. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
23. Deoxyribonucleotide-containing RNAs: A novel class of templates for HIV-i reverse transcriptase
24. Syncytium-inducing and non-syncytium-inducing capacity of H1 subtypes other than B: Phenotypic and genotypic characteristics
25. Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans. Correlation with cytotoxic T cell epitopes
26. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxiT lymphocytes
27. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1
28. Immunodominant epitope regions of HIV-1 reverse transcriptase: Correlations of HIV-1+ serum IgG inhibitory to polymerase activity with disease progression
29. Recombinant polypeptides from the human immunodeficiency virus reverse transcriptase define three epitopes recognized by antibodies in sera from patients with acquired immunodeficiency syndrome
30. Identification of a major human immunodeficiency virus-1 reverse transcriptase epitope recognised by mouse CD4+ T-lymphocytes
31. Human immunodeficiency virus-1 reverse transcriptase immunodominant CD4+ T-cell epitopes: A peptide-based multiparametric assessment in the mouse
32. Two highly antigenic sites in the human immunodeficiency virus type I reverse transcriptase
33. Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNase H activities
34. Identification of HIV-1 cytotoxic T-lymphocyte epitopes and implications for vaccine development
35. Immunization with soluble protein-pulsed spleen cells induces class I-restricted cytotoxic T-lymphocytes that recognize immunodominant epitopic peptides from Plasmodium falciparum and HIV-1
36. Interaction of C-terminal sequences of human deficiency virus reverse transcriptase with template primer
37. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 resolution shows bent DNA
38. Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: Definition of the minimal polymerase domain
39. Site-specific mutagenesis of AIDS virus reverse transcriptase
40. Identification of the primer binding domain in human immunodeficiency virus reverse transcriptase
41. HIV-1 reverse transcriptase structure-function relationships
42. Crystal structure at 3.5 resolution of HIV-1 reverse transcriptase complexed with an inhibitor
43. Intracellular neutralization of virus by immunoglobulin A antibodies
44. Penetration of antinuclear antibodies into immunoregulatory T cells: Pathogenic role in the connectional tissue diseases
45. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo
46. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1
47. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice
48. DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen
49. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors